Ketamine as a therapeutic agent for depression and pain: mechanisms and evidence
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ketamine as a therapeutic agent for depression and pain: mechanisms and evidence
Authors
Keywords
Ketamine, Esketamine, Major depressive disorder, Interventional psychiatry, Pain
Journal
JOURNAL OF THE NEUROLOGICAL SCIENCES
Volume 434, Issue -, Pages 120152
Publisher
Elsevier BV
Online
2022-01-14
DOI
10.1016/j.jns.2022.120152
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ketamine rapidly enhances glutamate-evoked dendritic spinogenesis in medial prefrontal cortex through dopaminergic mechanisms
- (2021) Mingzheng Wu et al. BIOLOGICAL PSYCHIATRY
- Antidepressant drugs act by directly binding to TRKB neurotrophin receptors
- (2021) Plinio C. Casarotto et al. CELL
- Strategies to Prolong Ketamine’s Efficacy in Adults with Treatment-Resistant Depression
- (2021) Eric P. McMullen et al. ADVANCES IN THERAPY
- Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation
- (2021) Roger S. McIntyre et al. AMERICAN JOURNAL OF PSYCHIATRY
- Plasma inflammatory cytokines and treatment-resistant depression with comorbid pain: improvement by ketamine
- (2021) Yanling Zhou et al. Journal of Neuroinflammation
- Microglial NMDA receptors drive pro‐inflammatory responses via PARP‐1/TRMP2 signaling
- (2020) Prajwal Raghunatha et al. GLIA
- Ascending‐Dose Study of Controlled‐Release Ketamine Tablets in Healthy Volunteers: Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability
- (2020) Paul Glue et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Opioid system is necessary but not sufficient for antidepressive actions of ketamine in rodents
- (2020) Matthew E. Klein et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The potential role of the HCN1 ion channel and BDNF-mTOR signaling pathways and synaptic transmission in the alleviation of PTSD
- (2020) Lianghui Ni et al. Translational Psychiatry
- A randomized placebo-controlled PET study of ketamine´s effect on serotonin1B receptor binding in patients with SSRI-resistant depression
- (2020) Mikael Tiger et al. Translational Psychiatry
- Intranasal esketamine: A novel drug for treatment-resistant depression
- (2020) Farah Khorassani et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Cardiovascular effects of repeated subanaesthetic ketamine infusion in depression
- (2020) Yan-Ling Zhou et al. JOURNAL OF PSYCHOPHARMACOLOGY
- A randomized, double-blind, active placebo-controlled study of efficacy, safety, and durability of repeated vs single subanesthetic ketamine for treatment-resistant depression
- (2020) Paulo R. Shiroma et al. Translational Psychiatry
- Intranasal ketamine for acute pain management in children: A systematic review and meta-analysis
- (2020) Lucas Oliveira J. e Silva et al. AMERICAN JOURNAL OF EMERGENCY MEDICINE
- The Cardiovascular Effects of Newer Antidepressants in Older Adults and Those With or At High Risk for Cardiovascular Diseases
- (2020) Lauren M. Behlke et al. CNS DRUGS
- Comparative efficacy of racemic ketamine and esketamine for depression: a systematic review and meta-analysis
- (2020) Anees Bahji et al. JOURNAL OF AFFECTIVE DISORDERS
- Hypertension and orthostatic hypotension with venlafaxine treatment in depressed older adults
- (2020) Rafae Wathra et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Can Intraoperative Low-Dose R,S-Ketamine Prevent Depressive Symptoms After Surgery? The First Meta-Analysis of Clinical Trials
- (2020) Liwei Pang et al. Frontiers in Pharmacology
- A systematic review and meta-analysis of the efficacy of intravenous ketamine infusion for treatment resistant depression: January 2009 – January 2019
- (2020) Walter S. Marcantoni et al. JOURNAL OF AFFECTIVE DISORDERS
- Single, Repeated, and Maintenance Ketamine Infusions for Treatment-Resistant Depression: A Randomized Controlled Trial
- (2019) Jennifer L. Phillips et al. AMERICAN JOURNAL OF PSYCHIATRY
- Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study
- (2019) Vanina Popova et al. AMERICAN JOURNAL OF PSYCHIATRY
- Ketamine Infusions for Chronic Pain
- (2019) Vwaire Orhurhu et al. ANESTHESIA AND ANALGESIA
- Adjunctive ketamine and electroconvulsive therapy for major depressive disorder: A meta-analysis of randomized controlled trials
- (2019) Wei Zheng et al. JOURNAL OF AFFECTIVE DISORDERS
- Low-dose ketamine in painful orthopaedic surgery: a systematic review and meta-analysis
- (2019) J. Mark Riddell et al. BRITISH JOURNAL OF ANAESTHESIA
- Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1)
- (2019) Maggie Fedgchin et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Attenuation of antidepressant and antisuicidal effects of ketamine by opioid receptor antagonism
- (2019) Nolan R. Williams et al. MOLECULAR PSYCHIATRY
- A neural circuit for comorbid depressive symptoms in chronic pain
- (2019) Wenjie Zhou et al. NATURE NEUROSCIENCE
- Efficacy and Safety of Esketamine Nasal Spray Plus an Oral Antidepressant in Elderly Patients With Treatment-Resistant Depression—TRANSFORM-3
- (2019) Rachel Ochs-Ross et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- The Effect of a Single Dose of Intravenous Ketamine on Suicidal Ideation: A Systematic Review and Individual Participant Data Meta-Analysis
- (2018) Samuel T. Wilkinson et al. AMERICAN JOURNAL OF PSYCHIATRY
- Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study
- (2018) Carla M. Canuso et al. AMERICAN JOURNAL OF PSYCHIATRY
- Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms
- (2018) Panos Zanos et al. PHARMACOLOGICAL REVIEWS
- Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression
- (2018) Ella J. Daly et al. JAMA Psychiatry
- Oral Ketamine vs Placebo in Patients With Cancer-Related Neuropathic Pain
- (2018) Marie T. Fallon et al. JAMA Oncology
- Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism
- (2018) Nolan R. Williams et al. AMERICAN JOURNAL OF PSYCHIATRY
- Intraoperative ketamine for prevention of depressive symptoms after major surgery in older adults: an international, multicentre, double-blind, randomised clinical trial
- (2018) G.A. Mashour et al. BRITISH JOURNAL OF ANAESTHESIA
- Intraoperative S-ketamine for the reduction of opioid consumption and pain one year after spine surgery: A randomized clinical trial of opioid dependent patients
- (2018) R V Nielsen et al. EUROPEAN JOURNAL OF PAIN
- Untangling the complexity of opioid receptor function
- (2018) Rita J. Valentino et al. NEUROPSYCHOPHARMACOLOGY
- Lack of Opioid System in the Antidepressant Actions of Ketamine
- (2018) Kai Zhang et al. BIOLOGICAL PSYCHIATRY
- Case Report: Ketamine for Pain and Depression in Advanced Cancer
- (2018) Jessica Sexton et al. JOURNAL OF PALLIATIVE MEDICINE
- Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)
- (2018) Maurizio Fava et al. MOLECULAR PSYCHIATRY
- Effect of Intranasal Ketamine vs Fentanyl on Pain Reduction for Extremity Injuries in Children
- (2018) Theresa M. Frey et al. JAMA Pediatrics
- Change in cytokine levels is not associated with rapid antidepressant response to ketamine in treatment-resistant depression
- (2017) Minkyung Park et al. JOURNAL OF PSYCHIATRIC RESEARCH
- The effects of ketamine on dopaminergic function: meta-analysis and review of the implications for neuropsychiatric disorders
- (2017) M Kokkinou et al. MOLECULAR PSYCHIATRY
- Ketamine treatment involves medial prefrontal cortex serotonin to induce a rapid antidepressant-like activity in BALB/cJ mice
- (2017) T.H. Pham et al. NEUROPHARMACOLOGY
- A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders
- (2017) Gerard Sanacora et al. JAMA Psychiatry
- Recurrence of depressive disorders after interferon-induced depression
- (2017) W-C Chiu et al. Translational Psychiatry
- Altered peripheral immune profiles in treatment-resistant depression: response to ketamine and prediction of treatment outcome
- (2017) D D Kiraly et al. Translational Psychiatry
- A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression
- (2016) Jaskaran B. Singh et al. AMERICAN JOURNAL OF PSYCHIATRY
- A REVIEW OF KETAMINE ABUSE AND DIVERSION
- (2016) Sean Sassano-Higgins et al. DEPRESSION AND ANXIETY
- KETAMINE'S MECHANISM OF ACTION: A PATH TO RAPID-ACTING ANTIDEPRESSANTS
- (2016) Chadi G. Abdallah et al. DEPRESSION AND ANXIETY
- Transiently increased glutamate cycling in rat PFC is associated with rapid onset of antidepressant-like effects
- (2016) G M I Chowdhury et al. MOLECULAR PSYCHIATRY
- NMDAR inhibition-independent antidepressant actions of ketamine metabolites
- (2016) Panos Zanos et al. NATURE
- Dysregulation of the dopamine system in the pathophysiology of schizophrenia and depression
- (2016) Anthony A. Grace NATURE REVIEWS NEUROSCIENCE
- Neuropeptide S modulates the amygdaloidal HCN activities ( I h ) in rats: Implication in chronic pain
- (2016) Shuzhuo Zhang et al. NEUROPHARMACOLOGY
- Essential roles of AMPA receptor GluA1 phosphorylation and presynaptic HCN channels in fast-acting antidepressant responses of ketamine
- (2016) K. Zhang et al. Science Signaling
- Ninety-six hour ketamine infusion with co-administered clonidine for treatment-resistant depression: A pilot randomised controlled trial
- (2016) Eric J. Lenze et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Risks Associated with Misuse of Ketamine as a Rapid-Acting Antidepressant
- (2016) Weili Zhu et al. Neuroscience Bulletin
- Essential roles of AMPA receptor GluA1 phosphorylation and presynaptic HCN channels in fast-acting antidepressant responses of ketamine
- (2016) K. Zhang et al. Science Signaling
- What do monoamines do in pain modulation?
- (2016) Kirsty Bannister et al. Current Opinion in Supportive and Palliative Care
- Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression
- (2015) D. Jeffrey Newport et al. AMERICAN JOURNAL OF PSYCHIATRY
- Serum Interleukin-6 Is a Predictive Biomarker for Ketamine’s Antidepressant Effect in Treatment-Resistant Patients With Major Depression
- (2015) Jian-jun Yang et al. BIOLOGICAL PSYCHIATRY
- Cumulative meta-analysis of interleukins 6 and 1β, tumour necrosis factor α and C-reactive protein in patients with major depressive disorder
- (2015) Rita Haapakoski et al. BRAIN BEHAVIOR AND IMMUNITY
- Ketamine and phencyclidine: the good, the bad and the unexpected
- (2015) D Lodge et al. BRITISH JOURNAL OF PHARMACOLOGY
- Ketamine added to morphine or hydromorphone patient-controlled analgesia for acute postoperative pain in adults: a systematic review and meta-analysis of randomized trials
- (2015) Li Wang et al. Canadian Journal of Anesthesia-Journal canadien d anesthesie
- Effects of Low-Dose and Very Low-Dose Ketamine among Patients with Major Depression: a Systematic Review and Meta-Analysis
- (2015) Ying Xu et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Effect of intraoperative application of ketamine on postoperative depressed mood in patients undergoing elective orthopedic surgery
- (2015) Min Jiang et al. Journal of Anesthesia
- Structure–Activity Relationships of (+)-Naltrexone-Inspired Toll-like Receptor 4 (TLR4) Antagonists
- (2015) Brandon R. Selfridge et al. JOURNAL OF MEDICINAL CHEMISTRY
- Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis
- (2015) Nanna B Finnerup et al. LANCET NEUROLOGY
- The role of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors in depression: Central mediators of pathophysiology and antidepressant activity?
- (2015) Florian Freudenberg et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week study
- (2015) Y.-D. Hu et al. PSYCHOLOGICAL MEDICINE
- Ketamine and other N-methyl-D-aspartate receptor antagonists in the treatment of depression: a perspective review
- (2015) Nicolas D. Iadarola et al. Therapeutic Advances in Chronic Disease
- A systematic review and meta-analysis of ketamine for the prevention of persistent post-surgical pain
- (2014) E. D. MCNICOL et al. ACTA ANAESTHESIOLOGICA SCANDINAVICA
- A Word to the Wise About Ketamine
- (2014) Alan F. Schatzberg AMERICAN JOURNAL OF PSYCHIATRY
- A single infusion of ketamine improves depression scores in patients with anxious bipolar depression
- (2014) Dawn F Ionescu et al. BIPOLAR DISORDERS
- Neuropathic pain-induced depressive-like behavior and hippocampal neurogenesis and plasticity are dependent on TNFR1 signaling
- (2014) Anna Dellarole et al. BRAIN BEHAVIOR AND IMMUNITY
- Central antinociception induced by ketamine is mediated by endogenous opioids and μ- and δ-opioid receptors
- (2014) Daniela da Fonseca Pacheco et al. BRAIN RESEARCH
- Ketamine Safety and Tolerability in Clinical Trials for Treatment-Resistant Depression
- (2014) Le-Ben Wan et al. JOURNAL OF CLINICAL PSYCHIATRY
- Safety, Tolerability, and Clinical Effect of Low-Dose Buprenorphine for Treatment-Resistant Depression in Midlife and Older Adults
- (2014) Jordan F. Karp et al. JOURNAL OF CLINICAL PSYCHIATRY
- Serotonin-1A receptor stimulation mediates effects of a metabotropic glutamate 2/3 receptor antagonist, 2S-2-amino-2-(1S,2S-2-carboxycycloprop-1-yl)-3-(xanth-9-yl)propanoic acid (LY341495), and an N-methyl-D-aspartate receptor antagonist, ketamine, in the novelty-suppressed feeding test
- (2014) Kenichi Fukumoto et al. PSYCHOPHARMACOLOGY
- A possible mechanism of the nucleus accumbens and ventral pallidum 5-HT1B receptors underlying the antidepressant action of ketamine: a PET study with macaques
- (2014) H Yamanaka et al. Translational Psychiatry
- Intranasal Ketamine for Analgesia in the Emergency Department: A Prospective Observational Series
- (2013) Gary Andolfatto et al. ACADEMIC EMERGENCY MEDICINE
- Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial
- (2013) James W. Murrough et al. AMERICAN JOURNAL OF PSYCHIATRY
- Inhibition of HCN channels within the periaqueductal gray attenuates neuropathic pain in rats.
- (2013) Lu Du et al. BEHAVIORAL NEUROSCIENCE
- The role of HCN channels within the periaqueductal gray in neuropathic pain
- (2013) Lu Du et al. BRAIN RESEARCH
- Ketamine and Peripheral Inflammation
- (2013) Marc De Kock et al. CNS Neuroscience & Therapeutics
- Ketamine-induced antidepressant effects are associated with AMPA receptors-mediated upregulation of mTOR and BDNF in rat hippocampus and prefrontal cortex
- (2013) W. Zhou et al. EUROPEAN PSYCHIATRY
- Neurophysiology of HCN channels: From cellular functions to multiple regulations
- (2013) Chao He et al. PROGRESS IN NEUROBIOLOGY
- Ketamine exerts antidepressant effects and reduces IL-1β and IL-6 levels in rat prefrontal cortex and hippocampus
- (2013) CHUN YANG et al. Experimental and Therapeutic Medicine
- Estimation of the Contribution of Norketamine to Ketamine-induced Acute Pain Relief and Neurocognitive Impairment in Healthy Volunteers
- (2012) Erik Olofsen et al. ANESTHESIOLOGY
- Sub-anesthetic concentrations of (R,S)-ketamine metabolites inhibit acetylcholine-evoked currents in α7 nicotinic acetylcholine receptors
- (2012) Ruin Moaddel et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Enhancement of Dorsal Hippocampal Activity by Knockdown of HCN1 Channels Leads to Anxiolytic- and Antidepressant-like Behaviors
- (2012) Chung Sub Kim et al. NEURON
- Deconstructing the Neuropathic Pain Phenotype to Reveal Neural Mechanisms
- (2012) Christian A. von Hehn et al. NEURON
- The neuropathic component in persistent postsurgical pain: A systematic literature review
- (2012) Simon Haroutiunian et al. PAIN
- Molecular Mechanisms of Opioid Receptor-dependent Signaling and Behavior
- (2011) Ream Al-Hasani et al. ANESTHESIOLOGY
- Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression
- (2011) Hiroyuki Koike et al. BEHAVIOURAL BRAIN RESEARCH
- Glutamate N-methyl-D-aspartate Receptor Antagonists Rapidly Reverse Behavioral and Synaptic Deficits Caused by Chronic Stress Exposure
- (2011) Nanxin Li et al. BIOLOGICAL PSYCHIATRY
- A systematic review of intravenous ketamine for postoperative analgesia
- (2011) Kevin Laskowski et al. Canadian Journal of Anesthesia-Journal canadien d anesthesie
- Absence of long-term analgesic effect from a short-term S-ketamine infusion on fibromyalgia pain: A randomized, prospective, double blind, active placebo-controlled trial
- (2011) Ingeborg Noppers et al. EUROPEAN JOURNAL OF PAIN
- Inhibition of spinal astrocytic c-Jun N-terminal kinase (JNK) activation correlates with the analgesic effects of ketamine in neuropathic pain
- (2011) Xiao-Peng Mei et al. Journal of Neuroinflammation
- Microglial Ca2+-Activated K+ Channels Are Possible Molecular Targets for the Analgesic Effects of S-Ketamine on Neuropathic Pain
- (2011) Y. Hayashi et al. JOURNAL OF NEUROSCIENCE
- Progressive increase in striatal dopamine synthesis capacity as patients develop psychosis: a PET study
- (2011) O Howes et al. MOLECULAR PSYCHIATRY
- NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
- (2011) Anita E. Autry et al. NATURE
- A Critical Role for GluN2B-Containing NMDA Receptors in Cortical Development and Function
- (2011) Chih-Chieh Wang et al. NEURON
- Ketamine-associated lower urinary tract destruction: a new radiological challenge
- (2010) K. Mason et al. CLINICAL RADIOLOGY
- Enantioselective capillary electrophoresis for identification and characterization of human cytochrome P450 enzymes which metabolize ketamine and norketamine in vitro
- (2010) Simone Portmann et al. JOURNAL OF CHROMATOGRAPHY A
- Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders
- (2010) Giles E. Hardingham et al. NATURE REVIEWS NEUROSCIENCE
- Spinal hyperpolarization-activated cyclic nucleotide-gated cation channels at primary afferent terminals contribute to chronic pain
- (2010) Keiko Takasu et al. PAIN
- Social Interaction Prevents the Development of Depressive-Like Behavior Post Nerve Injury in Mice: A Potential Role for Oxytocin
- (2010) Greg J. Norman et al. PSYCHOSOMATIC MEDICINE
- mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
- (2010) N. Li et al. SCIENCE
- Elevated Striatal Dopamine Function Linked to Prodromal Signs of Schizophrenia
- (2009) Oliver D. Howes et al. ARCHIVES OF GENERAL PSYCHIATRY
- A Meta-Analysis of Cytokines in Major Depression
- (2009) Yekta Dowlati et al. BIOLOGICAL PSYCHIATRY
- Role of interleukin-1β during pain and inflammation
- (2009) Ke Ren et al. BRAIN RESEARCH REVIEWS
- Development of a Sublingual/Oral Formulation of Ketamine for Use in Neuropathic Pain
- (2009) Chui Chong et al. CLINICAL DRUG INVESTIGATION
- Ketamine-associated bladder dysfunction
- (2009) Tsung-Hsun Tsai et al. INTERNATIONAL JOURNAL OF UROLOGY
- HCN1 Channel Subunits Are a Molecular Substrate for Hypnotic Actions of Ketamine
- (2009) X. Chen et al. JOURNAL OF NEUROSCIENCE
- Central Sensitization: A Generator of Pain Hypersensitivity by Central Neural Plasticity
- (2009) Alban Latremoliere et al. JOURNAL OF PAIN
- HCN hyperpolarization-activated cation channels inhibit EPSPs by interactions with M-type K+ channels
- (2009) Meena S George et al. NATURE NEUROSCIENCE
- Outpatient intravenous ketamine for the treatment of complex regional pain syndrome: A double-blind placebo controlled study
- (2009) Robert J. Schwartzman et al. PAIN
- Associations of Depression With C-Reactive Protein, IL-1, and IL-6: A Meta-Analysis
- (2009) M Bryant Howren et al. PSYCHOSOMATIC MEDICINE
- Chronic post-surgical pain: 10 years on
- (2008) W.A. Macrae BRITISH JOURNAL OF ANAESTHESIA
- Antidepressants modulate the in vitro inhibitory effects of propofol and ketamine on norepinephrine and serotonin transporter function
- (2008) Yejun Zhao et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Metabonomic analysis identifies molecular changes associated with the pathophysiology and drug treatment of bipolar disorder
- (2008) M J Lan et al. MOLECULAR PSYCHIATRY
- On the relationship between emotion and cognition
- (2008) Luiz Pessoa NATURE REVIEWS NEUROSCIENCE
- Attentional bias to incentive stimuli in frequent ketamine users
- (2008) C. J. A. Morgan et al. PSYCHOLOGICAL MEDICINE
- Cellular Mechanisms Underlying the Antidepressant Effects of Ketamine: Role of α-Amino-3-Hydroxy-5-Methylisoxazole-4-Propionic Acid Receptors
- (2007) Sungho Maeng et al. BIOLOGICAL PSYCHIATRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search